These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1696926)

  • 1. Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients.
    Berkvens TM; van Ormondt H; Gerritsen EJ; Khan PM; van der Eb AJ
    Genomics; 1990 Aug; 7(4):486-90. PubMed ID: 1696926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
    Markert ML; Hutton JJ; Wiginton DA; States JC; Kaufman RE
    J Clin Invest; 1988 May; 81(5):1323-7. PubMed ID: 3366897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.
    Berkvens TM; Gerritsen EJ; Oldenburg M; Breukel C; Wijnen JT; van Ormondt H; Vossen JM; van der Eb AJ; Meera Khan P
    Nucleic Acids Res; 1987 Nov; 15(22):9365-78. PubMed ID: 3684597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.
    Valerio D; Dekker BM; Duyvesteyn MG; van der Voorn L; Berkvens TM; van Ormondt H; van der Eb AJ
    EMBO J; 1986 Jan; 5(1):113-9. PubMed ID: 3007108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
    Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
    Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
    Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.
    Herbschleb-Voogt E; Pearson PL; Vossen JM; Meera Khan P
    Hum Genet; 1981; 56(3):379-86. PubMed ID: 7239521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
    Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
    J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
    Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
    J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
    Bonthron DT; Markham AF; Ginsburg D; Orkin SH
    J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
    Markert ML; Norby-Slycord C; Ward FE
    Am J Hum Genet; 1989 Sep; 45(3):354-61. PubMed ID: 2773932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence requirements for transcriptional arrest in exon 1 of the murine adenosine deaminase gene.
    Ramamurthy V; Maa MC; Harless ML; Wright DA; Kellems RE
    Mol Cell Biol; 1990 Apr; 10(4):1484-91. PubMed ID: 1690842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic cell genetics of adenosine deaminase expression and severe combined immunodeficiency disease in humans.
    Koch G; Shows TB
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4211-5. PubMed ID: 6933468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.
    Akeson AL; Wiginton DA; Dusing MR; States JC; Hutton JJ
    J Biol Chem; 1988 Nov; 263(31):16291-6. PubMed ID: 3182793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.
    Herbschleb-Voogt E; Scholten JW; Meera Khan P
    Hum Genet; 1983; 63(2):121-5. PubMed ID: 6840756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase: characterization and expression of a gene with a remarkable promoter.
    Valerio D; Duyvesteyn MG; Dekker BM; Weeda G; Berkvens TM; van der Voorn L; van Ormondt H; van der Eb AJ
    EMBO J; 1985 Feb; 4(2):437-43. PubMed ID: 3839456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
    Shovlin CL; Simmonds HA; Fairbanks LD; Deacock SJ; Hughes JM; Lechler RI; Webster AD; Sun XM; Webb JC; Soutar AK
    J Immunol; 1994 Sep; 153(5):2331-9. PubMed ID: 8051429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of transcriptional arrest sites in exon 1 of the human adenosine deaminase gene.
    Chen Z; Harless ML; Wright DA; Kellems RE
    Mol Cell Biol; 1990 Sep; 10(9):4555-64. PubMed ID: 1697031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and mutant human adenosine deaminase genes.
    Akeson AL; Wiginton DA; Hutton JJ
    J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.